Avidity Partners Management LP Quant / Systematic

Location: Dallas, TX

CIK: 0001791827 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $439M (100.0% shares, 0.0% debt)

Holdings (43)

DNTH DIANTHUS THERAPEUTICS INC 28.7%
Value $126M Shares 3,204,184 Est. Cost $21.50 Unrealized +18.9%
CGON CG ONCOLOGY INC 14.7%
Value $64.48M Shares 1,600,899 Est. Cost $33.90 Unrealized -14.2%
MDT MEDTRONIC PLC 4.1%
Value $18.15M Shares 190,600 Est. Cost $91.27 Unrealized 0.0%
BSX BOSTON SCIENTIFIC CORP 3.7%
Value $16.04M Shares 164,300 Est. Cost $49.10 Unrealized +110.9%
ORKA ORUKA THERAPEUTICS INC 2.9%
Value $12.7M Shares 660,424 Est. Cost $25.47 Unrealized -41.8%
BMY BRISTOL-MYERS SQUIBB CO 2.6%
Value $11.62M Shares 257,600 Est. Cost $45.51 Unrealized 0.0%
NTRA NATERA INC 2.6%
Value $11.33M Shares 70,400 Est. Cost $95.53 Unrealized +65.6%
DHR DANAHER CORPORATION 2.5%
Value $10.84M Shares 54,700 Est. Cost $205.28 Unrealized -3.4%
TEVA TEVA PHARMACEUTICAL INDS LTD 2.3%
Value $10.3M Shares 510,000 Est. Cost $15.79 Unrealized
CATX PERSPECTIVE THERAPEUTICS INC 2.3%
Value $10.27M Shares 2,994,033 Est. Cost $10.27 Unrealized -64.5%
JBIO JADE BIOSCIENCES INC 2.2%
Value $9.728M Shares 1,127,186 Est. Cost $33.31 Unrealized -75.5%
PFE PFIZER INC 2.1%
Value $9.336M Shares 366,400 Est. Cost $24.14 Unrealized 0.0%
TMO THERMO FISHER SCIENTIFIC INC 2.1%
Value $9.167M Shares 18,900 Est. Cost $475.70 Unrealized -2.3%
CNTX CONTEXT THERAPEUTICS INC 2.0%
Value $8.702M Shares 8,981,855 Est. Cost $1.57 Unrealized -48.4%
GMAB GENMAB A/S 1.7%
Value $7.609M Shares 248,100 Est. Cost $20.66 Unrealized
METSERA INC 1.7%
Value $7.352M Shares 140,500 Est. Cost $52.33 Unrealized
UNH UNITEDHEALTH GROUP INC 1.4%
Value $6.146M Shares 17,800 Est. Cost $548.30 Unrealized -45.5%
ARVN ARVINAS INC 1.4%
Value $5.95M Shares 698,363 Est. Cost $21.58 Unrealized -64.9%
COR CENCORA INC 1.4%
Value $5.938M Shares 19,000 Est. Cost $249.56 Unrealized +17.6%
EHC ENCOMPASS HEALTH CORP 1.2%
Value $5.322M Shares 41,900 Est. Cost $113.68 Unrealized +4.4%
JNJ JOHNSON & JOHNSON 1.1%
Value $4.969M Shares 26,800 Est. Cost $169.51 Unrealized 0.0%
CI THE CIGNA GROUP 1.1%
Value $4.785M Shares 16,600 Est. Cost $293.19 Unrealized 0.0%
ABBV ABBVIE INC 1.0%
Value $4.584M Shares 19,800 Est. Cost $201.95 Unrealized 0.0%
MCK MCKESSON CORP 1.0%
Value $4.481M Shares 5,800 Est. Cost $703.74 Unrealized -0.1%
CARL CARLSMED INC 1.0%
Value $4.31M Shares 321,912 Est. Cost $13.67 Unrealized 0.0%
KVUE KENVUE INC 1.0%
Value $4.304M Shares 265,200 Est. Cost $20.06 Unrealized 0.0%
IMUX IMMUNIC INC 0.9%
Value $4.143M Shares 4,699,411 Est. Cost $1.22 Unrealized -27.7%
ARQT ARCUTIS BIOTHERAPEUTICS INC 0.9%
Value $4.041M Shares 214,400 Est. Cost $14.02 Unrealized +12.5%
EXAS EXACT SCIENCES CORP 0.9%
Value $4.027M Shares 73,600 Est. Cost $55.79 Unrealized -10.4%
PHAT PHATHOM PHARMACEUTICALS INC 0.8%
Value $3.602M Shares 306,000 Est. Cost $16.93 Unrealized -39.0%
RGEN REPLIGEN CORP 0.7%
Value $3.115M Shares 23,300 Est. Cost $127.25 Unrealized -4.5%
ACAD ACADIA PHARMACEUTICALS INC 0.7%
Value $3.073M Shares 144,000 Est. Cost $23.65 Unrealized 0.0%
ASND ASCENDIS PHARMA A/S 0.7%
Value $2.883M Shares 14,500 Est. Cost $198.81 Unrealized
ELVN ENLIVEN THERAPEUTICS INC 0.7%
Value $2.872M Shares 140,300 Est. Cost $20.27 Unrealized -0.5%
BEAM BEAM THERAPEUTICS INC 0.6%
Value $2.718M Shares 112,000 Est. Cost $26.20 Unrealized -24.1%
SCYX SCYNEXIS INC 0.6%
Value $2.58M Shares 3,350,528 Est. Cost $1.57 Unrealized -46.1%
HQY HEALTHEQUITY INC 0.5%
Value $2.398M Shares 25,300 Est. Cost $101.38 Unrealized -7.2%
WVE WAVE LIFE SCIENCES LTD 0.5%
Value $2.178M Shares 297,500 Est. Cost $8.09 Unrealized 0.0%
XENE XENON PHARMACEUTICALS INC 0.5%
Value $2.144M Shares 53,400 Est. Cost $37.48 Unrealized -6.0%
AKERO THERAPEUTICS INC 0.4%
Value $1.923M Shares 40,500 Est. Cost $42.50 Unrealized
INSM INSMED INC 0.4%
Value $1.671M Shares 11,600 Est. Cost $48.37 Unrealized +153.3%
KPTI KARYOPHARM THERAPEUTICS INC 0.2%
Value $880K Shares 134,566 Est. Cost $8.54 Unrealized -37.0%
IMRX IMMUNEERING CORP 0.1%
Value $636K Shares 90,900 Est. Cost $5.19 Unrealized 0.0%